Molecular targets involved in histamine release and inflammatory cytokine production

The phrase “molecular targets involved in histamine release and inflammatory cytokine production” does not refer to a unique molecule or established canonical target. It encompasses a group of **histamine receptors** (principally H1R and H4R), **mast cells**, and related signaling pathways that mediate histamine-induced immune responses and the production of pro-inflammatory cytokines such as IL-6, TNF-α, and others. These molecular entities are of therapeutic interest in allergy, asthma, and other inflammatory diseases. Specific drugs target these receptors to block histamine effects and reduce cytokine-driven inflammation, but the precise target(s) should be named for structured pharmacological data (e.g., “Histamine H4 receptor”)[1][2][3][5][6][7].

Blockade of histamine receptor (prevents histamine binding and downstream signaling); Inhibition of mast cell degranulation (reduces histamine/cytokine release); Inhibition of intracellular signaling pathways (e.g., p38 MAPK, NF-κB for cytokine regulation); Inhibition of chemotaxis (by interfering with H4R-mediated cell migration).